Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroprotection”

337 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 337 results

Early research (Phase 1)Looking for participantsNCT07688746
What this trial is testing

Neonatal White Matter Injury Trial (WRAP)

Who this might be right for
White Matter InjuryBrain Injury, Fetus and NeonateNeonatal Brain Injury+2 more
Bridget LaMonica Ostrem, M.D., Ph.D. 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT03176186
What this trial is testing

Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest

Who this might be right for
Post-Cardiac Arrest Syndrome
Invero Pharma, Inc. 1,436
Post-approval studies (Phase 4)Study completedNCT06437639
What this trial is testing

MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)

Who this might be right for
Primary Open-Angle Glaucoma (POAG)
Pharmasoft 80
Large-scale testing (Phase 3)Study completedNCT01188811
What this trial is testing

Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Chronic Progressive
VA Office of Research and Development 54
Testing effectiveness (Phase 2)Study completedNCT04486430
What this trial is testing

Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset

Who this might be right for
StrokeCerebral Infarction
Beijing Tiantan Hospital 236
Not applicableUnknownNCT04297345
What this trial is testing

Feasibility and Safety Study to Evaluate the Neuroprotective Effect of Hemodialysis in Acute Ischemic Stroke

Who this might be right for
Cerebrovascular Stroke
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 20
Testing effectiveness (Phase 2)Study completedNCT00728182
What this trial is testing

Evaluating Neuroprotection in Aneurysm Coiling Therapy

Who this might be right for
Stroke
NoNO Inc. 185
Not applicableActive Not RecruitingNCT04261569
What this trial is testing

Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT)

Who this might be right for
Very Early Stage of Parkinson's Disease
University Hospital, Grenoble 14
Not applicableStudy completedNCT05404373
What this trial is testing

Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke

Who this might be right for
Stroke, AcuteNeuroprotectionEndovascular Treatment
Capital Medical University 100
Testing effectiveness (Phase 2)Study completedNCT01502046
What this trial is testing

Neuroprotection by Cannabinoids in Huntington's Disease

Who this might be right for
Huntington's Disease
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 25
Not applicableWithdrawnNCT01675388
What this trial is testing

Hypothermia During ECMO to Decrease Brain Injury

Who this might be right for
Neonatal Respiratory Failure
Sood, Beena G., MD, MS
Not applicableStudy completedNCT01340417
What this trial is testing

Melatonin Levels in Preterm and Term Newborn Infants

Who this might be right for
Pregnancy Preterm
Assistance Publique - Hôpitaux de Paris 380
Not applicableStudy completedNCT03609125
What this trial is testing

Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma

Who this might be right for
GlaucomaNeuro-Degenerative Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Early research (Phase 1)Study completedNCT01408472
What this trial is testing

NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement

Who this might be right for
Glaucoma, Primary Open Angle
Jeffrey L Goldberg 11
Not applicableUnknownNCT04762342
What this trial is testing

Power Training in Older Multiple Sclerosis Patients

Who this might be right for
Multiple SclerosisSclerosisDemyelinating Autoimmune Diseases, CNS+4 more
University of Aarhus 60
Testing effectiveness (Phase 2)Study completedNCT00525668
What this trial is testing

Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Charite University, Berlin, Germany 120
Not applicableUnknownNCT04554797
What this trial is testing

Regional Hypothermia in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

Who this might be right for
StrokeNeuroprotectionHypothermia
Capital Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT01073813
What this trial is testing

Neuroprotection and Repair in Optic Neuritis

Who this might be right for
Multiple SclerosisOptic Neuritis
University of Calgary 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02862938
What this trial is testing

Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration

Who this might be right for
Glaucoma
Stanford University 54
Not applicableUnknownNCT01231789
What this trial is testing

The Neuroprotection of Remote Ischemic Preconditioning (RIPC) on Cardiac Surgery in Multicenter

Who this might be right for
Cardiac Surgery Patients
Xijing Hospital 150
Next Page